Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. sits in the top decile of US sponsors by registered trial count (#238 of 15,742 sponsors by registered trial count).
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.: 102 sponsored US clinical trials, none currently recruiting.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. sponsors 102 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 83 completed. 38 of these trials are in Phase 3-4 (later-stage) and 62 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.
Top-decile sponsor footprint
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ranks in the top decile of sponsors by registered trial count (#238 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
83 of 102 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
102 total, page 3 of 3
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
NCT00050440
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
NCT00073203
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 33 |
| Phase 2 | 29 |
| Phase 3 | 32 |
| Phase 4 | 6 |
Therapeutic Areas
How the Johnson & Johnson Pharmaceutical Research & Development, L.L.C. early-phase archive is shaped
102 indexed studies, none listed as recruiting (0% open); 83 completed (81%).
Phase mix: 38 late (III/IV) vs 62 early (I/II) (early-phase heavy).
Top condition: Healthy (3 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.: archived-pipeline peers nationwide
Peers matched on 102 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 102 archived trials
- Butler Hospital · 103 trials · 9% recruiting
- Spaulding Rehabilitation Hospital · 101 trials · 19% recruiting
- Boston University Charles River Campus · 104 trials · 22% recruiting
- Kessler Foundation · 104 trials · 33% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Johnson & Johnson Pharmaceutical Research & Development, L.L.C. page
102 registered trials is a research-attention snapshot, not an endorsement of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. or any single study.
- None of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Johnson & Johnson Pharmaceutical Research & Development, L.L.C. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. pipeline card: 102 registered trials from official public datasets.Report a data error.